1. Home
  2. LEGN vs AGNC Comparison

LEGN vs AGNC Comparison

Compare LEGN & AGNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • AGNC
  • Stock Information
  • Founded
  • LEGN 2014
  • AGNC 2008
  • Country
  • LEGN United States
  • AGNC United States
  • Employees
  • LEGN N/A
  • AGNC N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • AGNC Real Estate Investment Trusts
  • Sector
  • LEGN Health Care
  • AGNC Real Estate
  • Exchange
  • LEGN Nasdaq
  • AGNC Nasdaq
  • Market Cap
  • LEGN 6.7B
  • AGNC 10.7B
  • IPO Year
  • LEGN 2020
  • AGNC 2008
  • Fundamental
  • Price
  • LEGN $35.16
  • AGNC $10.10
  • Analyst Decision
  • LEGN Strong Buy
  • AGNC Buy
  • Analyst Count
  • LEGN 12
  • AGNC 8
  • Target Price
  • LEGN $73.36
  • AGNC $9.63
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • AGNC 19.8M
  • Earning Date
  • LEGN 11-11-2025
  • AGNC 10-20-2025
  • Dividend Yield
  • LEGN N/A
  • AGNC 14.26%
  • EPS Growth
  • LEGN N/A
  • AGNC N/A
  • EPS
  • LEGN N/A
  • AGNC 0.26
  • Revenue
  • LEGN $796,838,000.00
  • AGNC $496,000,000.00
  • Revenue This Year
  • LEGN $70.75
  • AGNC $9.87
  • Revenue Next Year
  • LEGN $52.47
  • AGNC $58.56
  • P/E Ratio
  • LEGN N/A
  • AGNC $39.24
  • Revenue Growth
  • LEGN 74.75
  • AGNC N/A
  • 52 Week Low
  • LEGN $27.34
  • AGNC $7.85
  • 52 Week High
  • LEGN $51.77
  • AGNC $10.85
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 49.17
  • AGNC 56.78
  • Support Level
  • LEGN $32.70
  • AGNC $10.09
  • Resistance Level
  • LEGN $34.71
  • AGNC $10.31
  • Average True Range (ATR)
  • LEGN 1.24
  • AGNC 0.15
  • MACD
  • LEGN 0.15
  • AGNC -0.02
  • Stochastic Oscillator
  • LEGN 65.13
  • AGNC 58.54

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About AGNC AGNC Investment Corp.

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

Share on Social Networks: